Changeflow GovPing Healthcare & Life Sciences IRBM Azole SHP2 Inhibitors Patent EP4345101A1
Routine Notice Added Final

IRBM Azole SHP2 Inhibitors Patent EP4345101A1

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4345101A1, filed by IRBM S.P.A. and C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening, covering azole derivatives as SHP2 inhibitors for therapeutic use. The application includes claims for treating cancer, immune disorders, and respiratory conditions, with inventors including Alessia Petrochchi, Christian Montalbetti, Romano Di Fabio, Alina Ciammaichella, and Ilaria Rossetti. The publication is designated for all European member states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

The EPO published patent application EP4345101A1 for azole derivatives serving as SHP2 protein inhibitors. The applicants are IRBM S.P.A. and C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening, with the invention covering therapeutic applications including oncology indications and immune modulation. SHP2 is a protein tyrosine phosphatase implicated in cancer cell signaling pathways.

Pharmaceutical researchers and drug developers working in oncology or immunology should review the patent claims to assess potential freedom-to-operate implications. Competitors developing SHP2 inhibitors for cancer or autoimmune applications may need to evaluate whether the azole derivative claims conflict with their own research programs.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

AZOLE DERIVATIVES AS SHP2 INHIBITORS

Publication EP4345101A1 Kind: A1 Apr 15, 2026

Applicants

IRBM S.P.A., C.N.C.C.S. S.c.a.r.l. Collezione Nazionale
Dei Composti Chimici e Centro Screening

Inventors

PETROCCHI, Alessia, MONTALBETTI, Christian, DI FABIO, Romano, CIAMMAICHELLA, Alina, ROSSETTI, Ilaria

IPC Classifications

C07D 471/20 20060101AFI20230223BHEP A61K 31/438 20060101ALI20230223BHEP A61P 35/00 20060101ALI20230223BHEP A61P 35/02 20060101ALI20230223BHEP A61P 35/04 20060101ALI20230223BHEP A61P 9/00 20060101ALI20230223BHEP A61P 37/00 20060101ALI20230223BHEP A61P 37/02 20060101ALI20230223BHEP A61P 37/06 20060101ALI20230223BHEP A61P 11/00 20060101ALI20230223BHEP A61P 27/00 20060101ALI20230223BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4345101A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application publication Drug discovery research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!